This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Cilian Ag, Sanofi Pasteur Sa. Active years: 2013-2018.
Location History:
- Muenster, DE (2013)
- Münster, DE (2018)
Company Filing History:
Years Active: 2013-2018
Title: Jenny Apelt: Innovator in Monoclonal Antibody Expression
Introduction
Jenny Apelt is a prominent inventor based in Münster, Germany. She has made significant contributions to the field of biotechnology, particularly in the expression of monoclonal antibodies and viral proteins. With a total of 2 patents, her work has the potential to impact various applications in medicine and research.
Latest Patents
Jenny's latest patents include two innovative systems. The first patent, titled "Expression of monoclonal antibodies in ciliate host cells," relates to a system for the heterologous expression of a monoclonal antibody (mAb) or a fragment or derivative thereof. This system comprises at least one ciliate host cell, which incorporates at least one heterologous nucleic acid molecule encoding for the monoclonal antibody or its derivatives. The second patent, "System for the heterologous expression of a viral protein in a ciliate host cell," focuses on a system for the heterologous expression of a viral protein or a fragment thereof, also utilizing ciliate host cells.
Career Highlights
Throughout her career, Jenny has worked with notable companies in the biotechnology sector, including Cilian AG and Sanofi Pasteur SA. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in the field.
Collaborations
Jenny has collaborated with several professionals in her field, including Marcus Hartmann and Christine Sachse. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Jenny Apelt is a remarkable inventor whose work in monoclonal antibody expression and viral protein systems showcases her dedication to advancing biotechnology. Her contributions are poised to make a lasting impact in the industry.